Local Steroid Therapy As the First-line Treatment for Boys with Symptomatic Phimosis - a Long-term Prospective Study
Overview
Affiliations
Aim: Phimosis is a common paediatric urological disorder and often necessitates circumcision. We prospectively evaluated local steroid therapy (LST) as the first choice therapy for such children.
Methods: Two hundred and sixty symptomatic boys up to 15 years of age (mean 34 months) with phimosis were started on betamethasone dipropionate (0.05%) application on gently stretched prepuce twice a day. Follow-up visits were arranged at the end of weeks 1, 2 and 4 and 6 months. Grade of phimosis was objectively graded.
Results: Ninety one percent of the boys showed a successful outcome at the end of 4 weeks; 72% responded in first week, further 16% responded in week 2, and only 2.6% achieved alleviation of phimosis on further application of LST beyond 2 weeks. Fourty two (17.8%) boys had a recurrence of phimosis on a long-term follow-up (mean - 25.4 months, range 6-48 months); thus, the long-term success rate was 77%, while 60 (23%) boys underwent surgery.
Conclusion: Local steroid therapy is safe and successful in alleviating symptomatic tight foreskin in a large majority of children. The response can be seen as early as 1 week; most of the children respond by week 2 and continuing therapy further may not be very effective.
Chung E, Polikarpov D, Mazure H, James A, Doosti H, Campbell D Transl Androl Urol. 2023; 12(7):1050-1061.
PMID: 37554529 PMC: 10406538. DOI: 10.21037/tau-23-91.
Zhou G, Yin J, Sun J, Zhu W, Jin S, Li S Front Pediatr. 2022; 10:1025899.
PMID: 36389352 PMC: 9664212. DOI: 10.3389/fped.2022.1025899.
Zhou G, Jiang M, Yang Z, Xu W, Li S J Paediatr Child Health. 2021; 57(12):1960-1965.
PMID: 34212436 PMC: 9290972. DOI: 10.1111/jpc.15628.
Sabino Borges L, Meirelles M, Bernardes N, de Castro F, Helmo F, Rocha L Afr J Paediatr Surg. 2020; 16(1):17-22.
PMID: 32952135 PMC: 7759080. DOI: 10.4103/ajps.AJPS_119_16.
Dave S, Afshar K, Braga L, Anderson P Can Urol Assoc J. 2018; 12(2):E76-E99.
PMID: 29381458 PMC: 5937400. DOI: 10.5489/cuaj.5033.